Boehringer Ingelheim International Gmbh

Merck Canada Inc.

André Giroux

Pierre Louis Beaulieu

Murray D Bailey

Cédrickx Godbout

Lee Fader

Martin Poirier

Francois Bilodeau

Rebekah J Carson

Julie Naud

Olivier Lepage

Michael John Boyd

Elisia Villemure

Benoît Moreau

Carl Thibeault

Sheldon N Crane

Simon Surprenant

Mathieu Parisien

Oliver Hucke

Maude A Poirier

Jean-Francois Chiasson

François Bilodeau

Mélissa Leblanc

Marc-André Joly

Maude Poirier

Jean-François Chiasson

Compounds of Formula (I) wherein n, m, R, R, R, R, R5 and R6 are defined herein, are useful for the treatment of cytomegalovirus disease and/or infection. 

Cytomegalovirus inhibitor compounds

Compounds of Formula (I) wherein n, A, R, R, Rand Rare defined herein, are useful for the treatment of cytomegalovirus disease and/or infection. 

Compounds of Formula I are disclosed: wherein A, R, R, R, R, R, R, Rand Rare defined herein. The compounds encompassed by Formula I include compounds which are HIV protease inhibitors. The compounds and their pharmaceutically acceptable salts are useful for the prophylaxis or treatment of infection by HIV and the prophylaxis, treatment, or delay in the onset of AIDS. The compounds and their salts can be employed as ingredients in pharmaceutical compositions, optionally in combination with other antivirals, immunomodulators, antibiotics or vaccines. 

HIV protease inhibitors

Growing community of inventors

Ste-Anne-de-Bellevue, Canada

André Giroux